Position in DERM
as of Mar 31, 2026
· filed Apr 6, 2026
Position Value
$473
-$930 QoQ
Shares Held
101
-44.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DERM Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GAMMA Investing LLC holds $6,004,464 across 46 Drug Manufacturers - Specialty & Generic names. DERM ranks #42 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
11,338 | $1,340,264 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,604 | $951,139 | |
| 3 | VTRS |
Viatris Inc
|
39,167 | $529,146 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
2,846 | $374,932 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
12,998 | $311,042 | |
| 6 | HLN |
Haleon plc
|
29,472 | $295,014 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
9,502 | $286,200 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
3,146 | $238,624 |
All Filings in DERM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $473 | 101 | Shares | Defined | 2026-04-06 | |
| 2025-12-31 | $1,403 | 182 | Shares | Defined | 2026-01-05 | |
| 2025-09-30 | $1,167 | 164 | Shares | Defined | 2025-10-02 | |
| No filing history on record for this holder in this stock. | ||||||